TRIM21 and systemic lupus erythematosus: As previously mentioned, TRIM21/Ro52, which is aberrantly expressed in SLE and pSS patients, regulates B cell homeostasis though NF‐κB pathway and thus drives the formation of lymphoma, especially mucosa-associated lymphoid tissue (MALT) lymphomas and DLBCL [89, 90].